Showing 1,281 - 1,300 results of 104,728 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((nn decrease) OR (fold decrease)) ))', query time: 1.32s Refine Results
  1. 1281
  2. 1282
  3. 1283
  4. 1284
  5. 1285
  6. 1286

    Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

    Published 2015
    “…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”
  7. 1287
  8. 1288
  9. 1289

    RNA analysis reveals a ~6-fold reduced coverage of exon 26 in the murine <i>Tg</i> gene. by Wendy J. Bailey (14926392)

    Published 2025
    “…<p>(A) <i>Tg</i> transcriptional coverage in B6NCrl (CRL) and B6NTac (Taconic) thyroid samples determined by RNAseq. …”
  10. 1290
  11. 1291
  12. 1292

    Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis by Laura V. Minard (349145)

    Published 2016
    “…The overall proportion of NSSPP beneficiaries dispensed a statin increased approximately 4-fold during the study period. …”
  13. 1293

    Mesothelin expression and RG7787 uptake is decreased in KLM-1-R. by Kevin Hollevoet (710450)

    Published 2015
    “…<p><b>A</b>: Surface mesothelin levels are 5-fold lower in resistant KLM-1 (KLM-1-R) compared to KLM-1. …”
  14. 1294
  15. 1295

    The number of behavioral arrests in DKO mice decreased following systemic atropine. by Mike Kalogiannis (224818)

    Published 2011
    “…<p>(A) Mean (± SEM) time per mouse spent in full behavioral arrests are plotted in 30 min bins across the entire recording period following IP injections of saline (open symbols) and atropine (0.5 mg/kg; filled symbols). …”
  16. 1296
  17. 1297
  18. 1298
  19. 1299

    GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

    Published 2021
    “…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10<sup>4</sup>) were plated in Transwell<sup>®</sup> inserts and allowed to invade for 1 week through a Matrigel<sup>™</sup> layer. …”
  20. 1300